Company / Free Cash Flow
Elanco Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$284.0M
FY2025
5-year range
$131.0M / $394.0M
FY2021-FY2025
Trend
-27.9%
vs FY2024
Sector context
#29 of 194
Health Care
What the data says
Elanco's free cash flow of $284M is higher than 85% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$176M in FY2020 to $394M in FY2024.
Based on SEC 10-K filings.
$284M in FY2025 with a 3-year CAGR of +0.4%. Top quartile in the Health Care sector.
Improved from $131M to $284M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 194This company $284.0M Sector average $470.6M
▼
-39.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, free cash flow decreased 27.9% year-over-year.
- Ranks #29 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $284.0M | -27.9% |
| FY2024 | $394.0M | +200.8% |
| FY2023 | $131.0M | -53.4% |
| FY2022 | $281.0M | -13.3% |
| FY2021 | $324.0M | +284.1% |
| FY2020 | -$176.0M | -309.5% |
| FY2019 | $84.0M | -76.2% |
| FY2018 | $352.8M | +369.1% |
| FY2017 | $75.2M | +64.9% |
| FY2016 | $45.6M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026